Predicting "Clinically Insignificant Prostate Cancer" With: Combined PSA density and Biopsy Features
(Prepared by Cecilia Lacks, PhD, from AUA presentation by William J. Catalona, MD and his Research Collaborators) INTRO: Active monitoring protocols, including “watchful waiting,” are being increasingly used to avoid unnecessary treatment for men with “clinically insignificant prostate cancer.” QUESTION:…